We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-15.18%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$506M
AUM Growth
-$198M
Cap. Flow
-$88.8M
Cap. Flow %
-17.55%
Top 10 Hldgs %
91.48%
Holding
42
New
10
Increased
4
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$17.6M
2
WGS icon
GeneDx Holdings
WGS
+$13.3M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.52M
4
IBRX icon
ImmunityBio
IBRX
+$2.45M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$802K

Top Sells

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$36M
2
PFE icon
Pfizer
PFE
+$24.6M
3
QDEL icon
QuidelOrtho
QDEL
+$15.6M
4
OPK icon
Opko Health
OPK
+$11.4M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.96M

Sector Composition

Rank Sector Weight
1 Healthcare 94.94%
2 Energy 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.7B
$508K 0.1%
2,412
– –
SLNO
27
DELISTED
Soleno Therapeutics
SLNO
$475K 0.09%
142,133
– –
OPK icon
28
PUT
Opko Health
OPK
$1.02B
$292K 0.06%
749,900
-7,400
-1% -$26.1K
BHVN
29
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$212K 0.04%
+20,000
New +$2.49M
QDEL icon
30
PUT
QuidelOrtho
QDEL
$838M
$200K 0.04%
+26,500
New +$2.82M
ABUS icon
31
Arbutus Biopharma
ABUS
$915M
$149K 0.03%
+50,000
New +$153K
PTIX
32
DELISTED
Performance Technologies
PTIX
$16K ﹤0.01%
357
-5,005
-93% -$298K
AGEN
33
PUT
Agenus
AGEN
$290M
– –
-15,198
Closed -$22K
ARKG icon
34
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
– –
-350,000
Closed -$1.08M
CCRN
35
DELISTED
Cross Country Healthcare
CCRN
– –
-71,000
Closed -$1.97M
PACB icon
36
PUT
Pacific Biosciences
PACB
$368M
– –
-67,000
Closed -$126K
PFE icon
37
Pfizer
PFE
$153B
– –
-475,000
Closed -$24.6M
SPY icon
38
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
– –
-500,000
Closed -$1.31M
VIR icon
39
Vir Biotechnology
VIR
$1.49B
– –
-861,008
Closed -$36M
VIR icon
40
PUT
Vir Biotechnology
VIR
$1.49B
– –
-287,600
Closed -$1.58M
XBIT icon
41
PUT
XBiotech
XBIT
$69.2M
– –
-500,000
Closed -$674K
MOTS
42
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
– –
-353
Closed -$49K
1
2

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Oracle Investment Management held 42 positions worth $506M, down 28% from $704M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Oracle Investment Management withdrew a net $88.8M in Q1 2022, closing 10 positions and reducing 14 holdings. Its most notable exit was Vir Biotechnology, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 97% a quarter earlier, followed by Energy.

Against the trend, Oracle Investment Management opened a new position in ARK Innovation ETF worth $16.6M.

  • Oracle Investment Management's largest Q1 2022 buy was ARK Innovation ETF: 250,000 shares worth $16.6M.
  • Oracle Investment Management added most to BioCryst Pharmaceuticals in Q1 2022, an estimated $802K increase.
  • Oracle Investment Management's biggest Q1 2022 reduction was QuidelOrtho, cutting an estimated $15.6M.
  • Oracle Investment Management fully exited Vir Biotechnology in Q1 2022, selling an estimated $36M.
  • Oracle Investment Management's ten largest holdings make up 91% of its $506M portfolio in Q1 2022.
  • Oracle Investment Management opened 10 new positions and closed 10 in Q1 2022.
  • Oracle Investment Management's portfolio value fell 28% quarter-over-quarter to $506M.

Based on Oracle Investment Management's 13F filing for Q1 2022, filed 16 May 2022.